Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine Modulation in Anorexia Nervosa
NCT04128683Phase 1Completed
- Sponsor
- University of California, San Diego
- Start
- Oct 2020
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of amisulpride and bromocriptine in anorexia nervosa (AN) (12 arms), sponsored by University of California, San Diego. Primary endpoints: Measurement of Brain Activation During a Prediction Error Taste Reward Task at Day 7 and Measurement of Brain Activation During Taste Stimulus Expectation at Day 7. Started Oct 2020; status: completed.
02
Drugs
amisulpridebromocriptine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04128683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04128683.